Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy.

MLA

Liu, Glenn, et al. “Phase I Clinical and Pharmacokinetic Study of Oral Penclomedine (NSC 338720) in Adults with Advanced Solid Malignancy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 8, no. 3, Mar. 2002, pp. 706–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11895899&authtype=sso&custid=ns315887.

APA

Liu, G., Berlin, J., Tutsch, K. D., Van Ummersen, L., Dresen, A., Marnocha, R., Arzomanian, R., Alberti, D., Feierabend, C., Binger, K., & Wilding, G. (2002). Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 8(3), 706–711.

Chicago

Liu, Glenn, Jordan Berlin, Kendra D Tutsch, Lynn Van Ummersen, Amy Dresen, Rebecca Marnocha, Rhoda Arzomanian, et al. 2002. “Phase I Clinical and Pharmacokinetic Study of Oral Penclomedine (NSC 338720) in Adults with Advanced Solid Malignancy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 8 (3): 706–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11895899&authtype=sso&custid=ns315887.